Abatacept, Rituximab, Tocilizumab and TNFi Biologics in RA Abatacept, Rituximab, Tocilizumab and TNFi Biologics in RA
How do these drugs for the treatment of rheumatoid arthritis compare in terms of efficacy and outcomes?Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 19, 2019 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Safety of Abatacept Compared With Other DMARDs in RA Safety of Abatacept Compared With Other DMARDs in RA
Find out how the safety profile for abatacept compared with that of other DMARDs for rheumatoid arthritis.Arthritis Research & Therapy (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 16, 2019 Category: Allergy & Immunology Tags: Rheumatology Journal Article Source Type: news
abatacept (Orencia)
Title: abatacept (Orencia)Category: MedicationsCreated: 2/8/2006 12:00:00 AMLast Editorial Review: 8/1/2019 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 1, 2019 Category: Rheumatology Source Type: news
MABs Successfully Treat Immunotherapy-Related Myocarditis MABs Successfully Treat Immunotherapy-Related Myocarditis
Alemtuzumab and abatacept were both successfully used in patients with steroid-refractory myocarditis that developed during treatment with immune checkpoint inhibitors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 19, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Abatacept for RA With COPD Safe (CME/CE)
(MedPage Today) -- No increased risks for pulmonary complications compared with other biologics (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 26, 2019 Category: Primary Care Source Type: news
For RA With COPD, Abatacept is Safe
(MedPage Today) -- No increased pulmonary risks compared with other biologics (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 21, 2019 Category: Primary Care Source Type: news
No Rise in Cancer Risk for RA Patients on Actemra
(MedPage Today) -- Similar to malignancy risk with TNF inhibitors and abatacept (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 14, 2019 Category: Primary Care Source Type: news
Abatecept Retention Longest When Used First-Line (CME/CE)
(MedPage Today) -- Also, starting abatacept sooner may improve efficacy in rheumatoid arthritis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 7, 2019 Category: Primary Care Source Type: news
Abatacept Retention Higher Without Prior Biologics
(MedPage Today) -- Earlier use in rheumatoid arthritis may improve efficacy (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 25, 2019 Category: Primary Care Source Type: news
Abatacept and Joint Surgery: The Best Time to Stop? (CME/CE)
(MedPage Today) -- Pre-surgical biologic hold for one dosing interval not tied to lower risk of hospitalized infection, other outcomes (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 21, 2019 Category: Primary Care Source Type: news
Stopping Biologics Before Joint Surgery: Is Earlier Better?
(MedPage Today) -- For abatacept, one dosing interval sufficed in RA patients (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 12, 2019 Category: Primary Care Source Type: news
Abatacept Versus TNF Inhibitors in RA: What Are the Risks of Infections? (CME/CE)
(MedPage Today) -- Reduced hospitalized infection risk in abatacept versus TNFi initiators, study found. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 2, 2019 Category: Primary Care Source Type: news
Infection Risk Lower With Orencia vs Anti-TNF
(MedPage Today) -- Increased risk for hospitalized infection with TNF inhibitors was driven largely by infliximab (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - December 26, 2018 Category: Primary Care Source Type: news
Two-Drug Regimen Fails to Stem Psoriasis Relapse
(MedPage Today) -- Study looks at costimulatory blockade with abatacept after stopping ustekinumab (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - December 18, 2018 Category: Primary Care Source Type: news
Abatacept Misses the Mark in Lupus Nephritis
(MedPage Today) -- But further analyses planned because of " provocative " findings (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - June 19, 2018 Category: Rheumatology Source Type: news
